Natixis Advisors LLC Acquires 53,625 Shares of Haleon plc (NYSE:HLN)

Natixis Advisors LLC lifted its holdings in shares of Haleon plc (NYSE:HLN) by 3.6% during the 4th quarter, HoldingsChannel.com reports. The firm owned 1,527,392 shares of the company’s stock after buying an additional 53,625 shares during the period. Natixis Advisors LLC’s holdings in Haleon were worth $14,571,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also modified their holdings of the business. First Eagle Investment Management LLC increased its position in Haleon by 4.7% during the fourth quarter. First Eagle Investment Management LLC now owns 2,104,289 shares of the company’s stock worth $20,075,000 after buying an additional 93,553 shares during the last quarter. Atala Financial Inc acquired a new position in shares of Haleon during the 4th quarter valued at about $104,000. EverSource Wealth Advisors LLC raised its stake in shares of Haleon by 23.2% in the 4th quarter. EverSource Wealth Advisors LLC now owns 14,601 shares of the company’s stock valued at $139,000 after acquiring an additional 2,747 shares in the last quarter. Sequoia Financial Advisors LLC raised its stake in shares of Haleon by 2.5% in the 4th quarter. Sequoia Financial Advisors LLC now owns 85,690 shares of the company’s stock valued at $814,000 after acquiring an additional 2,101 shares in the last quarter. Finally, HighTower Advisors LLC lifted its holdings in Haleon by 3.4% in the 4th quarter. HighTower Advisors LLC now owns 362,685 shares of the company’s stock worth $3,460,000 after purchasing an additional 11,890 shares during the last quarter. Institutional investors own 6.67% of the company’s stock.

Haleon Stock Performance

NYSE:HLN opened at $10.38 on Thursday. The firm’s 50-day moving average is $9.80 and its 200-day moving average is $9.88. The company has a market cap of $46.97 billion, a price-to-earnings ratio of 30.51, a PEG ratio of 2.82 and a beta of 0.25. The company has a debt-to-equity ratio of 0.44, a quick ratio of 0.58 and a current ratio of 0.84. Haleon plc has a 52-week low of $7.99 and a 52-week high of $10.80.

Haleon (NYSE:HLN) last posted its quarterly earnings results on Thursday, February 27th. The company reported $0.05 EPS for the quarter. Haleon had a return on equity of 14.76% and a net margin of 10.85%. The firm had revenue of $3.54 billion during the quarter, compared to analysts’ expectations of $3.38 billion. Equities research analysts anticipate that Haleon plc will post 0.43 earnings per share for the current year.

Haleon Increases Dividend

The firm also recently declared a — dividend, which will be paid on Thursday, June 5th. Shareholders of record on Friday, April 25th will be issued a $0.1166 dividend. This represents a yield of 1.6%. The ex-dividend date is Friday, April 25th. This is a positive change from Haleon’s previous — dividend of $0.05. Haleon’s payout ratio is 58.97%.

Analysts Set New Price Targets

A number of equities analysts have recently commented on the stock. HSBC reissued a “hold” rating on shares of Haleon in a research report on Wednesday, March 5th. Deutsche Bank Aktiengesellschaft reissued a “hold” rating on shares of Haleon in a research report on Monday, March 3rd. Morgan Stanley cut shares of Haleon from an “overweight” rating to an “equal weight” rating in a report on Friday, January 10th. Hsbc Global Res cut Haleon from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, March 5th. Finally, Sanford C. Bernstein lowered Haleon from an “outperform” rating to a “market perform” rating in a report on Wednesday, January 8th. Six research analysts have rated the stock with a hold rating, two have issued a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat, the company presently has an average rating of “Hold” and an average price target of $10.95.

Haleon Profile

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.